Morgan Stanley’s Achilles Therapeutics ACHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$38.5K Buy
2024
Q3
$16.8K Buy
2024
Q2
$7.28K Sell
2024
Q1
$22.8K Buy
2023
Q4
$36 Sell
2023
Q3
$45.5K Sell
2023
Q2
$68.8K Sell
2023
Q1
$272K Buy
2022
Q4
Sell
2022
Q3
$16K Buy
2022
Q2
$16K Buy
2022
Q1
$18K Sell
2021
Q4
$32K Buy